CN Patent

CN120225500A — 用于活性物质递送的脂质化合物及组合物

Assigned to Korea Research Institute of Bioscience and Biotechnology KRIBB · Expires 2025-06-27 · 1y expired

What this patent protects

本发明涉及一种新型脂质化合物及包含该化合物的脂质纳米颗粒(lipid nanoparticle：LNP)组合物。根据本发明所述的脂质化合物可以通过多价相互作用直接或间接与活性物质结合并包围活性物质，从而增加活性物质的结构稳定性。并且，包含所述脂质化合物的脂质纳米颗粒可以显著提高活性物质向细胞内的递送效率和活性，从而可用于疾病的治疗和预防。

USPTO Abstract

本发明涉及一种新型脂质化合物及包含该化合物的脂质纳米颗粒(lipid nanoparticle：LNP)组合物。根据本发明所述的脂质化合物可以通过多价相互作用直接或间接与活性物质结合并包围活性物质，从而增加活性物质的结构稳定性。并且，包含所述脂质化合物的脂质纳米颗粒可以显著提高活性物质向细胞内的递送效率和活性，从而可用于疾病的治疗和预防。

Drugs covered by this patent

Patent Metadata

Patent number
CN120225500A
Jurisdiction
CN
Classification
—
Expires
2025-06-27
Drug substance claim
No
Drug product claim
No
Assignee
Korea Research Institute of Bioscience and Biotechnology KRIBB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.